Back to Search
Start Over
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
- Source :
-
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Nov; Vol. 14 (11), pp. 3195-3196. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2193-8210
- Volume :
- 14
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Dermatology and therapy
- Accession number :
- 39424713
- Full Text :
- https://doi.org/10.1007/s13555-024-01269-y